What does APOTHEEK CREMERS do?

APOTHEEK CREMERS is a pharmacy in Gistel. Public Limited, started on 16 March 1961, 1 establishment.

What is the address of APOTHEEK CREMERS?

The registered office of APOTHEEK CREMERS is located at Nieuwpoortse Steenweg 72, 8470 Gistel.

Is APOTHEEK CREMERS still active?

Yes. According to the CBE (29 October 2026) APOTHEEK CREMERS is active, legal situation “Normale toestand”, started on 16 March 1961.

Is APOTHEEK CREMERS registered on Peppol?

Yes, APOTHEEK CREMERS is registered on the Peppol network with ID 0208:0405238977.

What is the enterprise number of APOTHEEK CREMERS?

The enterprise number of APOTHEEK CREMERS is BE0405238977.

When was APOTHEEK CREMERS founded?

APOTHEEK CREMERS was founded on 16 March 1961.

Who are the directors of APOTHEEK CREMERS?

According to the 2025 annual accounts, the directors of APOTHEEK CREMERS are: EURINVESTS BV.

Is APOTHEEK CREMERS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 March 1961; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK CREMERS make in 2025?

APOTHEEK CREMERS posted a profit after taxes of € 22,106 in financial year 2025.

What is the revenue of APOTHEEK CREMERS?

As a small company, APOTHEEK CREMERS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 382,389.

How much does an employee at APOTHEEK CREMERS earn?

The average wage cost per full-time employee at APOTHEEK CREMERS was € 77,400 in 2025: staff costs of € 208,846 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK CREMERS have?

According to the 2025 annual accounts, APOTHEEK CREMERS has 2.7 full-time equivalents (FTE).

APOTHEEK CREMERS (Public Limited) - Gistel - BE0405238977

Dossier APOTHEEK CREMERS, printed on 29 October 2026 from databakkes.be/en/0405238977/apotheek-cremers. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK CREMERS from Gistel, company number BE0405238977, closed financial year 2025 with a result of € 22,106 after tax. For that financial year APOTHEEK CREMERS recorded a gross margin of € 382,389 and equity of € 650,926. Compared with financial year 2024, the result moved from € 174,693 to € 22,106. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 650,926

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 22,106

▼ 87% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 172,537

▲ 80% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 589,426.

People and assets in 2025

Full-time equivalents

2.7

▲ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 208,846

▲ 19% vs 2024

€ 77,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 16,108

▲ € 15,821 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 293,857

▼ 15% vs 2024

€ 52,462 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 180,958

▲ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 64,863

▲ 102% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 372,035 Gross margin 2022: € 372,035 First fiscal year in the series	€ 454,274 Gross margin 2023: € 454,274 ▲ 22% vs 2022 (€ 372,035) Favourable step	€ 427,797 Gross margin 2024: € 427,797 ▼ 6% vs 2023 (€ 454,274) Unfavourable step	€ 382,389 Gross margin 2025: € 382,389 ▼ 11% vs 2024 (€ 427,797) Unfavourable step	▼ 11%
Profit after taxes	€ 81,404 Profit after taxes 2022: € 81,404 First fiscal year in the series	€ 124,377 Profit after taxes 2023: € 124,377 ▲ 53% vs 2022 (€ 81,404) Favourable step	€ 174,693 Profit after taxes 2024: € 174,693 ▲ 40% vs 2023 (€ 124,377) Favourable step	€ 22,106 Profit after taxes 2025: € 22,106 ▼ 87% vs 2024 (€ 174,693) Unfavourable step	▼ 87%
Equity	€ 489,750 Equity 2022: € 489,750 First fiscal year in the series	€ 554,127 Equity 2023: € 554,127 ▲ 13% vs 2022 (€ 489,750) Favourable step	€ 628,820 Equity 2024: € 628,820 ▲ 13% vs 2023 (€ 554,127) Favourable step	€ 650,926 Equity 2025: € 650,926 ▲ 4% vs 2024 (€ 628,820) Favourable step	▲ 4%
Total debts	€ 726,569 Total debts 2022: € 726,569 First fiscal year in the series	€ 666,308 Total debts 2023: € 666,308 ▼ 8% vs 2022 (€ 726,569) Favourable step	€ 627,723 Total debts 2024: € 627,723 ▼ 6% vs 2023 (€ 666,308) Favourable step	€ 621,046 Total debts 2025: € 621,046 ▼ 1% vs 2024 (€ 627,723) Favourable step	▼ 1%
Cash	€ 162,256 Cash 2022: € 162,256 First fiscal year in the series	€ 151,059 Cash 2023: € 151,059 ▼ 7% vs 2022 (€ 162,256) Unfavourable step	€ 95,694 Cash 2024: € 95,694 ▼ 37% vs 2023 (€ 151,059) Unfavourable step	€ 172,537 Cash 2025: € 172,537 ▲ 80% vs 2024 (€ 95,694) Favourable step	▲ 80%
Land & buildings	€ 421,429 Land & buildings 2022: € 421,429 First fiscal year in the series	€ 403,106 Land & buildings 2023: € 403,106 ▼ 4% vs 2022 (€ 421,429) Unchanged	€ 384,783 Land & buildings 2024: € 384,783 ▼ 5% vs 2023 (€ 403,106) Unchanged	€ 379,927 Land & buildings 2025: € 379,927 ▼ 1% vs 2024 (€ 384,783) Unchanged	▼ 1%
Retained profit	€ 428,250 Retained profit 2022: € 428,250 First fiscal year in the series	€ 492,627 Retained profit 2023: € 492,627 ▲ 15% vs 2022 (€ 428,250) Favourable step	€ 567,320 Retained profit 2024: € 567,320 ▲ 15% vs 2023 (€ 492,627) Favourable step	€ 589,426 Retained profit 2025: € 589,426 ▲ 4% vs 2024 (€ 567,320) Favourable step	▲ 4%
Dividend	€ 80,136 Dividend 2022: € 80,136 First fiscal year in the series	€ 60,000 Dividend 2023: € 60,000 ▼ 25% vs 2022 (€ 80,136) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▲ 67% vs 2023 (€ 60,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 100,000) Unchanged	▼ 100%
Bank debt	€ 449,462 Bank debt 2022: € 449,462 First fiscal year in the series	€ 397,887 Bank debt 2023: € 397,887 ▼ 11% vs 2022 (€ 449,462) Favourable step	€ 346,019 Bank debt 2024: € 346,019 ▼ 13% vs 2023 (€ 397,887) Favourable step	€ 293,857 Bank debt 2025: € 293,857 ▼ 15% vs 2024 (€ 346,019) Favourable step	▼ 15%
Balance sheet total	€ 1,216,319 Balance sheet total 2022: € 1,216,319 First fiscal year in the series	€ 1,220,435 Balance sheet total 2023: € 1,220,435 Unchanged (€ 1,216,319) Unchanged	€ 1,256,543 Balance sheet total 2024: € 1,256,543 ▲ 3% vs 2023 (€ 1,220,435) Unchanged	€ 1,271,972 Balance sheet total 2025: € 1,271,972 ▲ 1% vs 2024 (€ 1,256,543) Unchanged	▲ 1%
Employees (FTE)	2.9 Employees (FTE) 2022: 2.9 First fiscal year in the series	2.7 Employees (FTE) 2023: 2.7 ▼ 0.2 vs 2022 (2.9) Unchanged	2.1 Employees (FTE) 2024: 2.1 ▼ 0.6 vs 2023 (2.7) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▲ 0.6 vs 2024 (2.1) Unchanged	▲ 0.6

Key figures of APOTHEEK CREMERS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK CREMERS?

What happened at APOTHEEK CREMERS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 22,106 (▼ 87% vs 2024). Source: NBB ↗
Mar 16, 1961 Start of the company according to the CBE. KBO
Mar 1, 1961 New establishment in Gistel. KBO

In short

From € 81,404 profit in 2022 to € 22,106 profit in 2025.

Paid € 136,915 in corporate taxes since 2022.

Best year ever: 2024, with € 174,693 profit.

On average € 141,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

EURINVESTS 100%

The stake of EURINVESTS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK CREMERS

Behind APOTHEEK CREMERS is EURINVESTS BV. The shares are held by EURINVESTS (100%).

Directors

According to the 2025 annual accounts

EURINVESTS BV

Director · represented by Krist Nollet

Also active at: AVR, AVRIMMO, APOTHEEK DE MAZIERE, APOTHEEK VANACKERE, Apotheek Waterven, APOTHEEK MEENSEPOORT, NK INVEST, FLEXCARE +1 more

Shareholders

EURINVESTS

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwpoortse Steenweg 72

8470 Gistel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Wieder

Vereniging van Mede-eigenaars Residentie Papageno te Gistel, Nieuwpoortse Steenweg 72-72A en Nederenheirweg 32

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0405.238.977

VAT number

BE 0405.238.977

Registered office

Nieuwpoortse Steenweg 72, 8470 Gistel

Names & denominations

APOTHEEK CREMERS

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

16 March 1961

Peppol

Active · Active since 16 Jul 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK CREMERS

Financials

What happened to APOTHEEK CREMERS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions